Ajanta Pharma Ltd

Common Name

Ajanta Pharma

Country

India

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

9,628

Ticker

AJANTPHARM

Exchange

NATIONAL STOCK EXCHANGE OF INDIA

Website

www.ajantapharma.com

Description

Ajanta Pharma Ltd. is a leading pharmaceutical company engaged in the development, manufacture, and marketing of a wide range of branded and generic pharmaceuticals. Established in 1973, the company h... Show more

Financial Statements of Ajanta Pharma

Below are the financial statements of Ajanta Pharma, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of INR	2025	2024
Non-current assets	—	—
Property, plant and equipment	16,248.7^a	13,841.3^a
Capital work-in-progress	1,762.7^a	2,564.5^a
Right-of-use assets	906.3^a	804^a
Other intangible assets (other than self generated)	465.2^a	146.6^a
Financial assets	—	—
Investments	252.4^a	185.8^a
Other non-current financial assets	92.5^a	93.6^a
Deferred tax assets (net)	1,864.3^a	1,344.5^a
Income tax assets (net)	127.1^a	94.4^a
Total non-current assets	21,719.2^a	19,074.7^a
Current assets	—	—
Inventories	9,038.5^a	8,283.6^a
Financial assets	—	—
Investments	4,387.1^a	3,300.5^a
Trade receivables	11,827.4^a	12,468.4^a
Cash and cash equivalents	1,751.2^a	1,294.9^a
Bank balances other than cash and cash equivalents	11.2^a	12.8^a
Loans	25.4^a	339.6^a
Other financial assets	23.2^a	190.2^a
Other current assets	1,233^a	1,330.7^a
Assets classified as held for sale	133.3^a	88.5^a
Total current assets	28,430.3^a	27,309.2^a
Total assets	50,149.5^a	46,383.9^a
Equity	—	—
Equity share capital	250.7^a	252.7^a
Other equity	37,652.2^a	35,420.9^a
Total equity	37,902.9^a	35,673.6^a
Financial liabilities	—	—
Lease liabilities	347.2^a	235.2^a
Other financial liabilities	10.5^a	13.7^a
Non-current liabilities	—	—
Other non-current liabilities	20^a	23.4^a
Provisions	802.7^a	395.4^a
Deferred tax liabilities (net)	1,105.2^a	1,085^a
Total non-current liabilities	2,285.6^a	1,752.7^a
Financial liabilities	—	—
Borrowings	25.9^a	14.9^a
Lease liabilities	101.1^a	102.7^a
Trade payables	—	—
Total outstanding dues of micro enterprises and small enterprises; and	215.5^a	206.4^a
Total outstanding dues of creditors other than micro enterprises and small enterprises.	4,326.5^a	4,425.6^a
Other financial liabilities	3,742^a	2,980.3^a
Current liabilities	—	—
Other current liabilities	911.2^a	597.3^a
Provisions	233.5^a	177.6^a
Income tax liabilities (net)	405.3^a	447.7^a
Liabilities classified as held for sale	0^a	5.1^a
Total current liabilities	9,961^a	8,957.6^a
Total liabilities	12,246.6^a	10,710.3^a
Total equity and liabilities	50,149.5^a	46,383.9^a

Verified Sources Behind Ajanta Pharma’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Ajanta Pharma’s data sources below and access millions more through our Disclosure Search.

a. Ajanta Pharma's Annual Report 2025

Trace every data point back to Ajanta Pharma’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Ajanta Pharma Ltd

Financial Statements of Ajanta Pharma

Verified Sources Behind Ajanta Pharma’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Alkem Laboratories Ltd

IPCA Laboratories Ltd

Glenmark Pharmaceuticals Ltd

Abbott India Ltd

Emcure Pharmaceuticals Ltd

Gland Pharma Ltd